🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New: President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry’s top complaints with the Biden-era law. ⁦John Tozzi⁩ bloomberg.com/news/articles/…

⁦Madison Muller⁩ ⁦Bloomberg⁩ ⁦Bloomberg Originals⁩ linkedin.com/posts/madison-…

Novo Nordisk Teams Up With Hims and Ro to Sell Cheaper Wegovy Want to know what's up with the weight-loss market today? Follow Madison at Madison Muller

$LLY CEO David Ricks on $CVS/ $NVO formulary deal: "It feels a little bit like last decade, these...lock-up deals. We're not interested in exclusive deals." Added that traffic to LillyDirect is above expectations, and he feels the company has tapped into the right market.

New: The White House is said to be pulling its nomination of Janette Nesheiwat as Surgeon General, per sources. Story on Bloomberg Terminal via colleague Madison Muller (Madison Muller) and me.

Scoop with Josh Wingrove: The White House is pulling its nomination for Janette Nesheiwat to be US surgeon general. This is the second high-profile health nominee the WH has pulled just before they were due to appear in front of a Senate panel. bloomberg.com/news/articles/…

ICYMI: CVS’s drug-benefits unit, known as Caremark, negotiated a deal to make Wegovy more widely available to its customers — knocking Zepbound off its list of preferred drugs. The changes may impact a couple hundred thousand patients. More here: bloomberg.com/news/articles/…

Scoop: We got an early look at what RFK Jr. plans to tell a Senate committee later today when he testifies on the health department’s budget. 👀💰 Read the latest from me and Washington’s Finest Rachel Cohrs Zhang: bloomberg.com/news/articles/…

Extremely humbled to be named a NIHCM Investigative & General reporting finalist for our reporting on Ozempictown, USA! devin leonard Tanaz Meghjani

NEW: Empower Pharmacy, which calls itself the US’ “largest and most advanced” compounding pharmacy has used poor-quality ingredients, skirted regulations and pushed out or sued employees who raised concerns, an Endpoints News investigation found. endpts.com/pharmacy-empow…

Listening to Max Bayer talk ADCs with GSK and BioNTech 👨‍🔬🧬

“This is the first event where I haven’t fought with the audience,” Calley Means tells Max Bayer 🤣

“If they’re available at the pharmacy, people assume they’re overseen by the FDA, but unfortunately, in the case of these unapproved drugs, they aren’t.” Read the latest from Anna Edney ⬇️⬇️ bloomberg.com/news/articles/…?

New: The ouster of Lars Fruergaard Jorgensen — only the fifth CEO in Novo’s century-long history — marks a turning point in the race to dominate the pharmaceutical industry’s hottest market. More from me and Naomi Kresge here: ⬇️ bloomberg.com/news/features/…

US health officials are terminating a contract with Moderna worth up to $766 million to develop vaccines for bird flu. Story w/ Madison Muller bloomberg.com/news/articles/…

New: Hims is cutting more than 4% of its workforce. “While not easy, this step reflects our commitment to invest in the areas that will define our future,” a spokesperson told me. More here for Bloomberg⬇️ bloomberg.com/news/articles/…

Lilly's top oncology execs: If a cancer program needs a mid-stage trial, its too mid for Lilly. My look at Lilly's cancer pipeline revamp and its unconventional strategy: endpoints.news/phase-3-or-bus…